June 13 (Reuters) - FirstEnergy Corp:
* Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000
patients
* Boehringer Ingelheim says strongly disagrees with publication of Sipahi et al
in Lancet Oncology June 2010
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about FirstEnergy Corp click here:) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000
patients
* Boehringer Ingelheim says strongly disagrees with publication of Sipahi et al
in Lancet Oncology June 2010
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about FirstEnergy Corp click here:) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.